The DOI matches its Crossref record; 110 of the 110 references it cites were found in a registry or an index.
Matrix metalloproteinases (MMPs): Chemical–biological functions and (Q)SARs
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Golbraikh, A., & Tropsha, A. (2002) · Journal of Molecular Graphics and Modelling · doi:10.1016/s1093-3263(01)00123-1 · Cited by 3,735
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Bergers, G., Brekken, R., McMahon, G., Vu, T. H., Itoh, T., Tamaki, K., Tanzawa, K., Thorpe, P., Itohara, S., Werb, Z., et al. (2000) · Nature Cell Biology · doi:10.1038/35036374 · Cited by 2,797
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Tropsha, A., Gramatica, P., & Gombar, V. K. (2003) · QSAR & Combinatorial Science · doi:10.1002/qsar.200390007 · Cited by 2,188
Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M., & Werb, Z. (1998) · Cell · doi:10.1016/s0092-8674(00)81169-1 · Cited by 1,750
Strategies for MMP inhibition in cancer: innovations for the post-trial era
Overall, C. M., & López-Otín, C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc884 · Cited by 1,349
Eriksson, L., Jaworska, J., Worth, A. P., Cronin, M. T. D., McDowell, R. M., & Gramatica, P. (2003) · Environmental Health Perspectives · doi:10.1289/ehp.5758 · Cited by 1,325
Frisch, S. M., & Screaton, R. A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00251-9 · Cited by 1,249
Matrix metalloproteinases: a tail of a frog that became a prince
Brinckerhoff, C. E., & Matrisian, L. M. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm763 · Cited by 1,105
Cited by
Biochemical and Biological Attributes of Matrix Metalloproteinases
Cui, N., Hu, M., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.005 · Cited by 1,359
Vascular Endothelial Cell Biology: An Update
Krüger-Genge, A., Blocki, A., Franke, R.-P., & Jung, F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184411 · Cited by 1,163
The molecular mechanisms and therapeutic strategies of EMT in tumor progression and metastasis
Huang, Y., Hong, W., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01347-8 · Cited by 1,032
Molecular Mechanisms of Dermal Aging and Antiaging Approaches
Shin, J.-W., Kwon, S.-H., Choi, J.-Y., Na, J.-I., Huh, C.-H., Choi, H.-R., & Park, K.-C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092126 · Cited by 875
“MMPs are a family of ubiquitous endopeptidases that can degrade ECM proteins [18].”
BackgroundNeuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift
Jassam, Y. N., Izzy, S., Whalen, M., McGavern, D. B., & El Khoury, J. (2017) · Neuron · doi:10.1016/j.neuron.2017.07.010 · Cited by 799
Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease
Wang, X., & Khalil, R. A. (2018) · Advances in Pharmacology · doi:10.1016/bs.apha.2017.08.002 · Cited by 754
Structure and Function of Human Matrix Metalloproteinases
Laronha, H., & Caldeira, J. (2020) · Cells · doi:10.3390/cells9051076 · Cited by 609
“Over the next 20 years, several enzymes were purified, but it was in 1985 that the area has developed more significantly [16,21].”
BackgroundInfluentialGhosh, S., Banerjee, S., & Sil, P. C. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.05.022 · Cited by 491
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
EMT: Mechanisms and therapeutic implications
Singh, M., Yelle, N., Venugopal, C., & Singh, S. K. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.08.009 · Cited by 475
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Multifunctional intracellular matrix metalloproteinases: implications in disease
Bassiouni, W., Ali, M. A. M., & Schulz, R. (2021) · The FEBS Journal · doi:10.1111/febs.15701 · Cited by 377
Luchian, I., Goriuc, A., Sandu, D., & Covasa, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031806 · Cited by 358
Salinity Stress Responses and Adaptation Mechanisms in Eukaryotic Green Microalgae
Shetty, P., Gitau, M. M., & Maróti, G. (2019) · Cells · doi:10.3390/cells8121657 · Cited by 351
Gobin, E., Bagwell, K., Wagner, J., Mysona, D., Sandirasegarane, S., Smith, N., Bai, S., Sharma, A., Schleifer, R., & She, J.-X. (2019) · BMC Cancer · doi:10.1186/s12885-019-5768-0 · Cited by 338
4-Thiazolidinones: The advances continue…
Tripathi, A. C., Gupta, S. J., Fatima, G. N., Sonar, P. K., Verma, A., & Saraf, S. K. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.11.017 · Cited by 319
Sacitharan, P. K. (2019) · Subcellular Biochemistry · doi:10.1007/978-981-13-3681-2_6 · Cited by 308
Delaviz, Y., Finer, Y., & Santerre, J. P. (2014) · Dental Materials · doi:10.1016/j.dental.2013.08.201 · Cited by 292
Insulin-Like Growth Factor System in Cancer: Novel Targeted Therapies
Brahmkhatri, V. P., Prasanna, C., & Atreya, H. S. (2015) · BioMed Research International · doi:10.1155/2015/538019 · Cited by 279
Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery
Hu, Y., Dong, Z., & Liu, K. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02949-5 · Cited by 268
Soundararajan, P., & Kim, J. S. (2018) · Molecules · doi:10.3390/molecules23112983 · Cited by 268
Towards an arthritis flare-responsive drug delivery system
Joshi, N., Yan, J., Levy, S., Bhagchandani, S., Slaughter, K. V., Sherman, N. E., Amirault, J., Wang, Y., Riegel, L., He, X., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03691-1 · Cited by 253
Inhibition of matrix metalloproteinase 14 (MMP-14)-mediated cancer cell migration.
Zarrabi, K., Dufour, A., Li, J., Kuscu, C., Pulkoski-Gross, A., Zhi, J., Hu, Y., Sampson, N. S., Zucker, S., & Cao, J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.256644 · Cited by 188
Intricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions
Mittal, R., Patel, A. P., Debs, L. H., Nguyen, D., Patel, K., Grati, M., Mittal, J., Yan, D., Chapagain, P., & Liu, X. Z. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25430 · Cited by 179
Molecular pathways of cell-mediated degradation of fibrillar collagen
Sprangers, S., & Everts, V. (2019) · Matrix Biology · doi:10.1016/j.matbio.2017.11.008 · Cited by 102
Ramamonjisoa, N., & Ackerstaff, E. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00003 · Cited by 93
High Matrix Metalloproteinase Activity Is a Hallmark of Periapical Granulomas
de Paula-Silva, F. W. G., D'Silva, N. J., da Silva, L. A. B., & Kapila, Y. L. (2009) · Journal of Endodontics · doi:10.1016/j.joen.2009.06.008 · Cited by 65
“These data and our current findings underscore the importance of characterizing the profile of MMPs involved in periapical lesions prior to using pan-MMP inhibitors therapeutically that can non-specifically inhibit MMPs (23).”
ResultAmino Acids, Peptides, and Proteins
Dietzen, D. J. (2018) · Principles and Applications of Molecular Diagnostics · doi:10.1016/b978-0-12-816061-9.00013-8 · Cited by 82
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases
Ying, S., Jiang, Z., He, X., Yu, M., Chen, R., Chen, J., Ru, G., Chen, Y., Chen, W., Zhu, L., et al. (2017) · Disease Markers · doi:10.1155/2017/5756102 · Cited by 54
Morkmued, S., Clauss, F., Schuhbaur, B., Fraulob, V., Mathieu, E., Hemmerlé, J., Clevers, H., Koo, B.-K., Dollé, P., Bloch-Zupan, A., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-71749-6 · Cited by 25
Wang, H., Zhang, P., Yu, J., Zhang, F., Dai, W., & Yi, S. (2019) · Molecular Brain · doi:10.1186/s13041-019-0516-6 · Cited by 25
The role of matrix metalloproteinases in liver function and disease
Mitropoulou, G., Kompoura, V., Saffioti, F., & Mavroeidis, V. K. (2025) · Frontiers in Bioscience-Landmark · doi:10.31083/fbl27127 · Cited by 14
Metadata
- Authors
- Verma, R. P., & Hansch, C.
- Venue
- Bioorganic & Medicinal Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-03
- Volume
- 15
- Issue
- 6
- Pages
- 2223-2268
- ISSN
- 0968-0896 (ISSN-L)
- OpenAlex
- W2103868159
- Cited by
- 783
- References
- 110
- FWCI
- 8.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.